Management to hold webcast today at 5:00 pm Eastern New York, N.Y., Feb. 17, 2026 (GLOBE NEWSWIRE) — NANO Nuclear...
Reports
—Company Expects Full-Year 2026 BRINSUPRI® (brensocatib) Revenues to Be at Least $1 Billion; Reiterates Full-Year 2026 ARIKAYCE® (amikacin liposome inhalation suspension)...
Applied Digital Reports Fiscal Second Quarter 2026 Results DALLAS, Jan. 07, 2026 (GLOBE NEWSWIRE) --...
Cancer Immunotherapy, LYMPHIR™, launched in the U.S. in December 2025 Completed $36 million in strategic financings, of which $18 million...
Completed enrollment in LEGEND’s pivotal cohort with 125 patients in high-risk, BCG-unresponsive NMIBC with carcinoma in situ Reported preliminary 6-month...
Management to hold webcast today at 5:00 pm Eastern New York, N.Y., Dec. 18, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear...
